Published in:
Open Access
01-04-2018 | Validation Studies
The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
Authors:
Dirk Holzinger, Dirk Foell, Gerd Horneff, Ivan Foeldvari, Nikolay Tzaribachev, Catrin Tzaribachev, Kirsten Minden, Tilmann Kallinich, Gerd Ganser, Lucia Clara, Johannes-Peter Haas, Boris Hügle, Hans-Iko Huppertz, Frank Weller, Alessandro Consolaro, Francesca Bovis, Nicolino Ruperto, For the Paediatric Rheumatology International Trials Organisation (PRINTO)
Published in:
Rheumatology International
|
Special Issue 1/2018
Login to get access
Abstract
The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the German language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. The participating centres were asked to collect demographic and clinical data along the JAMAR questionnaire in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 319 JIA patients (2.8% systemic, 36.7% oligoarticular, 23.5% RF negative polyarthritis, and 37% other categories) and 100 healthy children were enrolled in eight centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the German version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and in clinical research.